top of page
Consultation d'affaires

Innovation
management

Practice area

Helping clients maximize commercial value by assisting with product launch, marketing, sales, and market access

Product launch

We have helped drive product launches for the most successful drugs on the market and have expertise in all therapeutic areas. Although launches are often complex, with products entering the market in multiple countries simultaneously, we can keep development on track. To help clients prepare for future launches, we focus on capability building during our studies and have created the Launch Academy training program.

​

​

Marketing

We support clients in creating high-impact strategies that maximize value, using customized tools. We also have detailed market data for all major geographic regions, including emerging markets (e.g., information on trends in India and China).

​

​

Sales

We help clients reach their full sales potential while maintaining efficiency. Our efforts span the entire organization—we can help train and restructure sales forces, work directly in the field to provide coaching, maximize value from back-office services, develop strategies to accelerate short-term sales, and assist with company-wide commercial transformations. We also have databases with information that can help companies maximize sales force effectiveness, such as the Institutional Segmentation and Targeting Tool (ISATT), which provides data on US hospital accounts.

​

​

Market access

We have a deep knowledge of global market access issues. Many payors are now reluctant to pay for new products, especially if they are more expensive than existing therapies. To overcome this challenge, we work with clients to develop compelling real world evidence in support of their drugs. We also assist clients with payor negotiations, helping them build trust-based relationships while simultaneously obtaining optimal reimbursement terms. In addition, we have supported several clients in the design and implementation of value-added services for patients, such as patient loyalty programs and medication co-pay cards.

+ 20%
improved margins
+ 22%
quality improvement
x 4-8
return on investment
8-17%
costs reduction
bottom of page